Diabetes mellitus and chronic renal insufficiency;Diabetes mellitus a chronická renálni insuficience

Vnitrni Lekarstvi

Volumn 49, Issue 5, 2003, Pages 395-402

  Rychlík, Ivan ^a   Sulkova S ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Chronic renal insufficiency; Diabetic nephropathy; Epidemiology; Regular dialyzation treatment

Indexed keywords

AGE; ARTICLE; BLOOD PRESSURE REGULATION; CHRONIC KIDNEY FAILURE; CZECH REPUBLIC; DEVELOPED COUNTRY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIALYSIS; DISEASE COURSE; ETHNOLOGY; GLUCOSE BLOOD LEVEL; HUMAN; INCIDENCE; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; PERITONEAL DIALYSIS; PREVALENCE; PROGNOSIS; QUALITY OF LIFE; RISK FACTOR; SEX; SURVIVAL;

DIABETIC NEPHROPATHIES; HUMANS; KIDNEY FAILURE, CHRONIC;

EID: 0038463920     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Akmal, M.: Hemodialysis in Diabetic Patients. Am. J. Kidney Dis., 38, Suppl. 1, 2001: S195-S199
2. Bednářová V, Sulková S: Léčba chronického selhání ledvin peritoneální dialýzou. Čas. Lék. čes., 135, 1996, 340-343
3. Blagg, C. R.: Visual and vascular problems in hemodialysis patients. Kidney Int., 6, Suppl. 1, 1974, S27-S30
4. Bommer, J.: Attaining long-term survival when treating diabetic patients with ESRD by hemodialysis. Adv. Ren. Replace. Ther., 8, 2001, 13-21
5. Bonnucchi, D., Capelli, G., Albertazi, A.: Which is the preferred vascular access in diabetic patients? A view from Europe. Nephrol. Dial. Transplant., 17, 2002, 2022
6. Bouček, P.: Hemodialýza u nemocnsých s diabetem. In: Sulková, S. et al.: Hemodialýza. Maxdorf Jessenius, Praha 2000, 477-490
7. De Vriese, A. S., Tilton, R. G., Stephan, C. C. et al.: Vascular endothelial growth factor is essential for hyperglycemia-induced structural and functional alternations of the peritoneal membrane. J. Am. Soc. Nephrol., 12, 2001, 1734-1741
8. Eggers, P. W., Gohdes, G., Pugh, J.: Nontraumatic lower extremity amputation in the Medicare end-stage renal disease population. Kidney Int., 56, 1999, 1524-1533
9. Foley, R. N., Parfrey, P. S.: Cardiac disease in the diabetic dialysis patient. Nephrol. Dial. Transplant., 13, 1998, 1112-1113
10. Chung, S. H., Lindholm, B., Lee, H. B.: Influence of initial nutritional status on continuous peritoneal dialysis patient survival. Perit. Dial. Int., 20, 2000, 19-26
11. Ifudu, O., Dulin, A. L., Friedman, E. A.: Interdialytic weight taint correlates with glycosylated hemoglobin in diabetic hemodialysis patients. Am. J. Kidney Dis., 23, 1994, 686-691
12. Jaar, B. G., Herman, J. A., Furth, S. L. et al.: Septicemia in diabetic hemodialysis patients: comparison of incidence, risk factors, and mortality with non-diabetic hemodialysis patients. Am. J. Kidney Dis., 35, 2000, 282-292
13. Joki, N., Ishikawa, H., Fuzakawa, R. et al.: Coronary artery disease as a definitive risk factor of shortterm outcome after starting hemodialysis in diabetic patients in diabetic renal failure. Clin. Nephrol., 55, 2001, 109-114
14. Joy, M. S., Cefalu, W. T., Hogan, S. L. et al.: Long-Term Glycemic Control Measurements in Diabetic Pastients Receiving Hemodialysis. Am. J. Kidney Dis., 39, 2002, 297-307
15. Kalousová, M., Zima, T., Tesař, V. et al.: Stanovení produktů pokročilé glykace a oxidace. Klin. Biochem. Metab., 21, 2002, 11-16
16. Lachmanová, J.: Statistická ročenka dialyzační léčby v České Republice 2000. Česká nefrologickí společnost, Praha, 2001
17. Lee, B. H., Chung, S. H., Chu, W. S. et al.: Peritoneal Dialysis in Diabetic Patients. Am. J. Kidney Dis., 38, Suppl. 1, 2001, S200-S203
18. Manske, C. L.: Hyperglycemia and Intensive glycemic control in diabetic patients with chronic renal disease. Am. J. Kidney Dis., 32, Suppl. 3, 1998, 157-171
19. Menon, M. K., Naimark, D. M., Bargman, J. M. et al.: Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function. Nephrol. Dial. Transplant., 16, 2001, 2207-2213
20. Morioka, T., Emoto, M., Tabata, T. et al.: Glycemic Control is a Predictor of Survival for Diabetic Patients on Hemodialysis. Diabetes Care, 24, 2001, 909-912
21. Passadakis, P., Thodis, E., Vargemezis, V. et al.: Long-term survival with peritoneal dialysis in ESRD due to diabetes. Clin. Nephrol., 56, 2001, 257-270
22. Passadakis, P., Thodis, E., Vargemezis, V. et al.: Recommendations for glucose control in diabetes on CAPD. Editorial. Int. J. Artif. Org., 22, 1999, 657-664
23. Raine, A. E. G. (on behalf of the EDTA Registry): Epidemiology, development and treatment of end stage renal failure in non insulin dependent diabetics in Europe. Diabetologia, 36, 1993, 1099-1104
24. Ritz, E., Rychlík, I., Locatelli, F. et al.: Endstage renal failure in type 2 diabetes - a medical catastrophe of worldwide dimensions. Am. J. Kidney Dis., 34, 1999, 795-808
25. Ritz, E., Rychlík, I.: Management of the patient with type 2 diabetes and renal failure. In: Nephropathy in Type 2 Diabetes. Ritz, E. and Rychlík, I. (eds.), Oxford University Press, 1999, 218-237
26. Ritz, E., Rychlík, I.: Diabetic Nephropathy - the Size of the Problem. In: Hasslacher, Ch., ed. Diabetic Nephropatby. John Wiley & Sons Ltd., Chichester, New York 2001, 3-17
27. Rodríguéz, J. A., Clčries, M., Vela, E. and Renal Registry Committee: Diabetic patients on renal replacement therapy: analysis of Catalan. Nephrol. Dial. Transplant., 12, 1997, 2501-2509
28. Rychlík I., Miltenberger-Miltenyi, G., Ritz, E.: The drama of the continuous increase in end-stage renal failure in patients with type II diabetes mellitus. Nephrol. Dial. Transplant., 13, 1998, Suppl. 8, 6-10
29. Rychlík, I., Berdych, M.: Epidemiology of Renal Disease in Patients with Diabetes Mellitus in the Czech Republic. In: Cardionephrology 6, eds. Timio, M., Wizemann, V., Venanzi, S., Editoriale Bios, Cosenza, 2000, 223-224
30. Rychlík, I., Berdych, M., Jaroš, M.: Diabetes mellitus 2.typu s nefropatií nediabetického typu. Aktuality v nefrologii, 7, 2001, 31-36
31. Schomig, M., Ritz, E.: Cardiovascular problems in diabetic patients on renal replacement therapy. Nephrol. Dial. Transplant., 15, Suppl. 5, 2000, 111-116
32. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the developent and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med., 329, 1993, 977
33. U.S. Renal Data System: USRDS 2000 Annual Data Report. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, April, 2000
34. Winkler, A. S., Marsden, J., Chaudhuri, K. R. et al.: Erythropoietin depletion and anaemia in diabetes mellitus. Diabet. Med., 16, 1999, 813-819
35. Wu, M. S., Yu, C. C., Yang, C. W. et al.: Poor pre-dialysis glycemic control is a predictor of mortality in type II diabetic patients on maintenance haemodialysis. Nephrol. Dial. Transplant., 12, 1997, 2105-2110
36. Yamamoto, T., Ozono, K., Miyauchi, A. et al.: Role of Advanced Glycation End Products in Adynamic Bone Disease in Patients With Diabetic Nephropathy. Am. J. Kidney Diseases, 38, Suppl. 1, 2001: S161-S164
37. Yun, Y. S., Lee, H. C., Yoo, N. C. et al.: Reduced erythropoietin responsiveness to anemia in diabetic patients before advanced diabetic nephropathy. Diabetes Res. Clin. Pract., 46, 1999, 223-229